Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine, ondansetron, and pethidine for prevention of postoperative shivering after abdominal surgery
IRCT20190708044155N1Phase 3Completed
- Sponsor
- Isfahan University of Medical Sciences
- Start
- Jun 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of dexmedetomidine, ondansetron and pethidine in postanesthetic shivering (PAS) (4 arms), sponsored by Isfahan University of Medical Sciences. Primary endpoints: Prevention of shivering after surgery and Severity of postoperative shivering. Started Jun 2019; status: completed.
02
Drugs
dexmedetomidineondansetronpethidine
03
Conditions
postanesthetic shivering (PAS)
Beyond the preview
Go deeper on IRCT20190708044155N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20190708044155N1.